Literature DB >> 12875608

Potential therapeutic properties of green tea polyphenols in Parkinson's disease.

Tianhong Pan1, Joseph Jankovic, Weidong Le.   

Abstract

Tea is one of the most frequently consumed beverages in the world. It is rich in polyphenols, a group of compounds that exhibit numerous biochemical activities. Green tea is not fermented and contains more catechins than black tea or oolong tea. Although clinical evidence is still limited, the circumstantial data from several recent studies suggest that green tea polyphenols may promote health and reduce disease occurrence, and possibly protect against Parkinson's disease and other neurodegenerative diseases. Green tea polyphenols have demonstrated neuroprotectant activity in cell cultures and animal models, such as the prevention of neurotoxin-induced cell injury. The biological properties of green tea polyphenols reported in the literature include antioxidant actions, free radical scavenging, iron-chelating properties, (3)H-dopamine and (3)H-methyl-4-phenylpyridine uptake inhibition, catechol-O-methyltransferase activity reduction, protein kinase C or extracellular signal-regulated kinases signal pathway activation, and cell survival/cell cycle gene modulation. All of these biological effects may benefit patients with Parkinson's disease. Despite numerous studies in recent years, the understanding of the biological activities and health benefits of green tea polyphenols is still very limited. Further in-depth studies are needed to investigate the safety and efficacy of green tea in humans and to determine the different mechanisms of green tea in neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875608     DOI: 10.2165/00002512-200320100-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  84 in total

1.  Marked reduction in the minimum inhibitory concentration (MIC) of beta-lactams in methicillin-resistant Staphylococcus aureus produced by epicatechin gallate, an ingredient of green tea (Camellia sinensis).

Authors:  S Shiota; M Shimizu; T Mizushima; H Ito; T Hatano; T Yoshida; T Tsuchiya
Journal:  Biol Pharm Bull       Date:  1999-12       Impact factor: 2.233

2.  A novel mechanism of dopamine neurotoxicity involving the peripheral extracellular and the plasma membrane dopamine transporter.

Authors:  Z Liu; J Zhang; J Fei; L Guo
Journal:  Neuroreport       Date:  2001-10-29       Impact factor: 1.837

3.  Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats.

Authors:  H Yokogoshi; M Kobayashi; M Mochizuki; T Terashima
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

4.  Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  T P Singer; N Castagnoli; R R Ramsay; A J Trevor
Journal:  J Neurochem       Date:  1987-07       Impact factor: 5.372

Review 5.  The importance of free radicals and catalytic metal ions in human diseases.

Authors:  B Halliwell; J M Gutteridge
Journal:  Mol Aspects Med       Date:  1985

6.  Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.

Authors:  K Nakagawa; T Miyazawa
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  1997-12       Impact factor: 2.000

7.  Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue.

Authors:  M Suganuma; S Okabe; M Oniyama; Y Tada; H Ito; H Fujiki
Journal:  Carcinogenesis       Date:  1998-10       Impact factor: 4.944

8.  Catechin metabolites after intake of green tea infusions.

Authors:  P G Pietta; P Simonetti; C Gardana; A Brusamolino; P Morazzoni; E Bombardelli
Journal:  Biofactors       Date:  1998       Impact factor: 6.113

Review 9.  Tea and cancer.

Authors:  C S Yang; Z Y Wang
Journal:  J Natl Cancer Inst       Date:  1993-07-07       Impact factor: 13.506

10.  In vivo antioxidant effect of green and black tea in man.

Authors:  M Serafini; A Ghiselli; A Ferro-Luzzi
Journal:  Eur J Clin Nutr       Date:  1996-01       Impact factor: 4.016

View more
  24 in total

1.  Effects of tea drinking on auditory functions in aged subjects.

Authors:  J H Hwang; Y C Chan; C J Hsu; T C Liu; J C Chen
Journal:  J Nutr Health Aging       Date:  2012-03       Impact factor: 4.075

2.  Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo.

Authors:  Zhen-tao Zhang; Xue-bing Cao; Nian Xiong; Hong-cai Wang; Jin-sha Huang; Sheng-gang Sun; Tao Wang
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

3.  Tea Consumption and Health-Related Quality of Life in Older Adults.

Authors:  C-W Pan; Q Ma; H-P Sun; Y Xu; N Luo; P Wang
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

4.  Neuroprotection by epigallo catechin gallate against bupivacaine anesthesia induced toxicity involves modulation of PI3/Akt/PTEN signalling in N2a and SH-SY5Y cells.

Authors:  Li-Yan Wang; Xia Li; Yu-Zeng Han
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin.

Authors:  Stéphane Bastianetto; Jonathan Brouillette; Rémi Quirion
Journal:  Neurochem Res       Date:  2007-04-04       Impact factor: 3.996

6.  Daily tea drinking is associated with a low level of depressive symptoms in the Finnish general population.

Authors:  Jukka Hintikka; Tommi Tolmunen; Kirsi Honkalampi; Kaisa Haatainen; Heli Koivumaa-Honkanen; Antti Tanskanen; Heimo Viinamäki
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

7.  Beneficial effects of green tea: a literature review.

Authors:  Sabu M Chacko; Priya T Thambi; Ramadasan Kuttan; Ikuo Nishigaki
Journal:  Chin Med       Date:  2010-04-06       Impact factor: 5.455

8.  Iron Chelators as Potential Therapeutic Agents for Parkinson's Disease.

Authors:  Carlos A Perez; Yong Tong; Maolin Guo
Journal:  Curr Bioact Compd       Date:  2008-10-01

Review 9.  Benefits from dietary polyphenols for brain aging and Alzheimer's disease.

Authors:  L Rossi; S Mazzitelli; M Arciello; C R Capo; G Rotilio
Journal:  Neurochem Res       Date:  2008-04-16       Impact factor: 4.414

10.  Dietary derived compounds in cancer chemoprevention.

Authors:  Ewa Langner; Wojciech Rzeski
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.